pipeline

  • HOME
  • pipeline
  • line up
pipeline
Inflammasome Inhibitors
Indication Optimization Pre-clinical ADMET/CMC Ph Ⅰ Ph Ⅱ
NuGel® Atopic Dermatitis
TO
NuSepin® COVID-19
IV
NuCerin® Alzheimer’s disease
PO
NuBesin® Obesity
PO
Oral Inflammasome Inhibitors
  • ˙IPF
  • ˙Ulcerative colitis
PO
Nanobody
Indication Optimization Pre-clinical ADMET/CMC Ph Ⅰ Ph Ⅱ
Papiliximab® (Anti-PD-L1xCD47) Oncology
IV
Saviximab®(Anti-SARS-CoV-2) SARS-CoV-2
IV
Undisclosed Oncology
IV

R&D collaboration : Dong-A ST
R&D collaboration : Korea Research Institute of Bioscience and Biotechnology